Why are Sponsors Turning to Smaller CROs?

The clinical trials industry has experienced a massive shift over the past decade. While trials were once conducted mainly by major pharma companies and managed by large CROs, smaller biotechs are now becoming major players.

Check out this article, written by our founder and CEO, Shane Needham, Ph.D., to learn more about how more nimble, specialized CROs are igniting change and improving clinical trial operations.

Read the Article